CNE100003PN0
CNE100003PN0
NOVORAY CORPORATION
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 32.96B EUR | 59.02B EUR | 20.3B EUR |
Enterprise Value | 32.48B EUR | 59.48B EUR | 20.56B EUR |
Valuation Multiples | |||
Trailing P/E | 109.19x | 198.54x | 71.75x |
Forward P/E | 54.82x | -- | -- |
Price to Sales | 26.89x | 49.11x | 18.37x |
Price to Book | 18.45x | 33.04x | 11.09x |
EV/Revenue | 26.5x | 49.5x | 18.61x |
EV/EBITDA | 83.26x | 174.94x | 63.44x |
Price to FCF (P/FCF) | 186.54x | 848.13x | 362.04x |
EV/FCF | 183.83x | 854.81x | 366.72x |
FCF Yield | 0.54% | 0.12% | 0.28% |